NCT01815580View on ClinicalTrials.gov

HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2020

Study Completion Date

June 30, 2021

Conditions
HIV
Interventions
DRUG

Atripla or Stribild

Antiretroviral therapy

Trial Locations (1)

Unknown

Asociación Civil Impacta Salud y Educación, Lima

Sponsors

Collaborators (1)

Epicentro, Peru
All Listed Sponsors
collaborator

Asociación Civil Impacta Salud y Educación, Peru

OTHER

collaborator

Asociación Civil Via Libre, Peru

OTHER

collaborator

Epicentro, Peru

UNKNOWN

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Fred Hutchinson Cancer Center

OTHER